Print Print
CKS is no longer commissioned by the National Institute for Health and Clinical Excellence (NICE). NICE remains committed to providing a replacement service for CKS and is currently reviewing its options. In the meantime, although CKS content is now not being maintained, it still remains relevant and will continue to be made available. CKS content was generated under a programme of topic creation and update. To check if the topic you are viewing is current or out of date, please refer to the topic publication details by clicking on the 'How up-to-date is this topic?' link in the left hand menu on individual topic pages.

Immunizations - travel vaccinations - How up-to-date is this topic?
Changes

Version 1.11, revision planned in 2011.

Last revised in July 2007

February 2011 — minor update. Brand name of tick-bourne encephalitis vaccine corrected to read TicoVac®. Issued in February 2011.

October 2010 — updated. Advice from the National Travel Health Network and Centre (NaTHNaC) for pilgrims for the Hajj and Umrah season of 1431 (2010) [NaTHNaC, 2010] has been added. Issued in November 2010.

September 2010 — minor update. A new edition of Health information for overseas travel, the 'Yellow Book', has been published [NaTHNaC, 2010] and has been included in this topic. Issued in September 2010.

August 2010 — minor update. Menveo®, a new quadrivalent meningococcal conjugate vaccine, is now recommended in preference to ACWY Vax® (polysaccharide vaccine) for all age groups requiring quadrivalent meningococcal vaccine. Issued in August 2010.

June 2010 — minor typographical correction. Issued in June 2010.

April 2010 — minor update. Prescriptions amended to indicate which travel vaccinations are not available on the NHS. Issued in April 2010.

June 2009 — updated to include information on IXIARO®, a Japanese encephalitis vaccine that has a UK product licence. Issued in June 2009.

November 2008 — minor update. Black triangle removed from cholera vaccine. Issued in December 2008.

March to July 2007 — converted from PRODIGY guidance to CKS topic structure. The evidence-base has been reviewed in detail, and recommendations are more clearly justified and transparently linked to the supporting evidence.

This CKS topic has been developed following the publication of the 'Green Book' (Immunisation against infectious disease) by the Department of Health.

© NHS Institute for Innovation and Improvement